Companies / Arbutus Biopharma Corp
Arbutus Biopharma Corp
Financials · FY2025
Ownership
197.8M shares outstanding · as of Aug 10, 2026
Ownership
| Insiders | 0.05% | 101,500 |
| Institutions | 62.45% | 123,552,852 |
| Public float | 37.50% | 74,193,483 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 3
View all →| Insider | % of shares | Shares |
|---|---|---|
Nguyen TuanChief Financial Officer | 0.04% | 73,500 |
Androski LindsayCEOPresident and CEO · Director | 0.01% | 28,000 |
Beardsley Robert ADirector | — | — |
Institutional holders 178
View all →| Holder | Value | % of shares |
|---|---|---|
| $128.44M | 13.50% | |
| $66.08M | 6.96% | |
| $64.18M | 6.74% | |
| $60.55M | 6.36% | |
| $44.46M | 4.67% | |
| $37.77M | 3.98% | |
| $26.05M | 2.74% | |
| $16.98M | 1.91% | |
| $11.99M | 1.35% | |
| $10.52M | 1.11% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $9.41M | +2.0M +33.19% | 7,869,179 3.98% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Trim | Common Stock | $-7.54M | -1.7M -38.59% | 2,664,941 1.35% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $3.42M | +713K +5.46% | 13,766,071 6.96% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common Stock | $2.89M | +642K | 642,448 0.32% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $1.84M | +382K +26.32% | 1,832,704 0.93% of shares | low |
| Q1 2026 as of | Hudson Bay Capital Management LP 13F manager | Trim | Common Stock | $-1.46M | -325K -48.15% | 350,000 0.18% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $862.4K | +224K +466.33% | 272,029 0.14% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Add | Common Stock | $557.4K | +180K +79.76% | 406,558 0.21% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Morgan Stanley | Passive13G/A | — |
| Two Seas Capital LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ABUS | Common Stock | 03879J100 |